Septic shock in adults: guidelines of the All-Russian public organization “Federation of Anesthesiologists and Reanimatologists”
暂无分享,去创建一个
K. M. Lebedinskii | V. Kuzkov | R. Lakhin | I. Zabolotskikh | A. Gritsan | M. Babaev | V. Rudnov | A. V. Kulikov | E. Shifman | S. Rey | D. Protsenko | A. Bykov | A. Smetkin | S. Shlyapnikov | M. Yarustovsky | A. V. Shchegolev | V. V. Kulabukhov | M. Kirov | M. A. Babaev | B. Z. Belotserkovskiy | V. L. Kupreichik | M. V. Surkov | R. Lakhin
[1] Nathan Nielsen,et al. Research priorities for therapeutic plasma exchange in critically ill patients , 2023, Intensive Care Medicine Experimental.
[2] R. Bellomo,et al. Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup , 2023, Nature Reviews Nephrology.
[3] R. Bellomo,et al. Hemoperfusion in the intensive care unit , 2022, Intensive Care Medicine.
[4] S. Sakka,et al. Extravascular lung water levels are associated with mortality: a systematic review and meta-analysis , 2022, Critical Care.
[5] Daryl A Jones,et al. Temporal changes in the epidemiology of sepsis‐related intensive care admissions from the emergency department in Australia and New Zealand , 2022, Emergency medicine Australasia : EMA.
[6] Song-Tao Shou,et al. Frequency and mortality of sepsis and septic shock in China: a systematic review and meta-analysis , 2022, BMC Infectious Diseases.
[7] B. Erstad,et al. Effect of fixed-dose hydrocortisone on vasopressor dose and mean arterial pressure in obese and nonobese patients with septic shock. , 2022, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[8] Shota Yamamoto,et al. ARDS Clinical Practice Guideline 2021 , 2022, Journal of Intensive Care.
[9] A. Khanna,et al. Timing of vasoactive agents and corticosteroid initiation in septic shock , 2022, Annals of Intensive Care.
[10] S. Shlyapnikov,et al. Application of Damage Control tactics in the treatment of patients with generalized peritonitis and septic shock , 2022, Grekov's Bulletin of Surgery.
[11] Parisa Rashidi,et al. Early Biomarker Signatures in Surgical Sepsis , 2022, The Journal of surgical research.
[12] R. Ferrer,et al. Fisiopatología del shock séptico , 2022, Medicina Intensiva.
[13] Jin Zhang,et al. Association of Blood Glucose Level and Glycemic Variability With Mortality in Sepsis Patients During ICU Hospitalization , 2022, Frontiers in Public Health.
[14] J. Vincent,et al. Septic shock: incidence, mortality and hospital readmission rates in French intensive care units from 2014 to 2018. , 2022, Anaesthesia, critical care & pain medicine.
[15] Youping Deng,et al. Association of Septic Shock with Mortality in Hospitalized COVID-19 Patients in Wuhan, China , 2022, Advances in virology.
[16] Fang Wang,et al. Continuous Renal Replacement Therapy With Adsorbing Filter oXiris in Acute Kidney Injury With Septic Shock: A Retrospective Observational Study , 2022, Frontiers in Medicine.
[17] H. Fujieda,et al. Comprehensive analysis of cytokine adsorption properties of polymethyl methacrylate (PMMA) membrane material , 2022, Journal of Artificial Organs.
[18] C. Ronco,et al. Clinical Assessment of Continuous Hemodialysis with the Medium Cutoff EMiC®2 Membrane in Patients with Septic Shock , 2022, Blood Purification.
[19] V. Jha,et al. Estimates of sepsis prevalence and outcomes in adult intensive care unit patients in India: a cross-sectional study. , 2022, Chest.
[20] Sameer S. Kadri,et al. Association Between Implementation of the Severe Sepsis and Septic Shock Early Management Bundle Performance Measure and Outcomes in Patients With Suspected Sepsis in US Hospitals , 2021, JAMA network open.
[21] C. Sprung,et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 , 2021, Intensive Care Medicine.
[22] T. Zewotir,et al. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients , 2021, BMC Infectious Diseases.
[23] Tobias Hübner,et al. First Evaluation of a New Dynamic Scoring System Intended to Support Prescription of Adjuvant CytoSorb Hemoadsorption Therapy in Patients with Septic Shock , 2021, Journal of clinical medicine.
[24] X. Qiu,et al. Multidimensional Evaluation of All-Cause Mortality Risk and Survival Analysis for Hospitalized Patients with COVID-19 , 2021, International journal of medical sciences.
[25] B. Allaouchiche,et al. Associations between peripheral perfusion disorders, mean arterial pressure and dose of norepinephrine administrated in the early phase of septic shock , 2021, Clinical and experimental pharmacology & physiology.
[26] K. Fushimi,et al. Effectiveness of polymyxin B hemoperfusion for sepsis depends on the baseline SOFA score: a nationwide observational study , 2021, Annals of Intensive Care.
[27] S. Gennai,et al. Lack of admission biomarkers' clinical utility in outcomes prediction in patients suspected with infection in the emergency department. , 2021, The American journal of emergency medicine.
[28] E. Ortiz-Prado,et al. Prolonged Capillary Refilling as a Predictor of Mortality in Patients With Septic Shock , 2021, Journal of intensive care medicine.
[29] K. Baharuddin,et al. Norepinephrine in Septic Shock: A Systematic Review and Meta-analysis , 2021, The western journal of emergency medicine.
[30] V. Singhal,et al. Proton pump inhibitor use and risk for recurrent Clostridioides difficile infection: A systematic review & meta-analysis. , 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[31] L. Camporota,et al. Clearance of inflammatory cytokines in patients with septic acute kidney injury during renal replacement therapy using the EMiC2 filter (Clic-AKI study) , 2020, Critical Care.
[32] S. di Saverio,et al. Damage Control Surgery may be a Safe Option for Severe Non-Trauma Peritonitis Management: Proposal of a New Decision-Making Algorithm , 2020, World Journal of Surgery.
[33] M. Singer,et al. Effect of Extracorporeal Blood Purification on Mortality in Sepsis: A Meta-Analysis and Trial Sequential Analysis , 2020, Blood Purification.
[34] B. Allaouchiche,et al. Core-to-skin temperature gradient measured by thermography predicts day-8 mortality in septic shock: A prospective observational study. , 2020, Journal of critical care.
[35] J. Bakker,et al. A lactate-targeted resuscitation strategy may be associated with higher mortality in patients with septic shock and normal capillary refill time: a post hoc analysis of the ANDROMEDA-SHOCK study , 2020, Annals of Intensive Care.
[36] L. Scott,et al. The therapeutic efficacy of adjunct therapeutic plasma exchange for septic shock with multiple organ failure: a single-center experience , 2020, Critical Care.
[37] A. Dhala,et al. Rapid Implementation and Innovative Applications of a Virtual Intensive Care Unit During the COVID-19 Pandemic: Case Study , 2020, Journal of medical Internet research.
[38] Dong Zhang,et al. Timing of norepinephrine initiation in patients with septic shock: a systematic review and meta-analysis , 2020, Critical Care.
[39] B. Allegranzi,et al. Epidemiology and burden of sepsis acquired in hospitals and intensive care units: a systematic review and meta-analysis , 2020, Intensive Care Medicine.
[40] Dimitris Bertsimas,et al. COVID-19 mortality risk assessment: An international multi-center study , 2020, medRxiv.
[41] P. Schlattmann,et al. Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis , 2020, Intensive Care Medicine.
[42] C. Sohn,et al. A mortality analysis of septic shock, vasoplegic shock and cryptic shock classified by the third international consensus definitions (Sepsis‐3) , 2020, The clinical respiratory journal.
[43] F. Guirgis,et al. Time to vasopressor initiation and organ failure progression in early septic shock , 2020, Journal of the American College of Emergency Physicians open.
[44] R. Bellomo,et al. Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference , 2020, Kidney international.
[45] Fang Zhang,et al. Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use , 2020, JAMA network open.
[46] Daryl A Jones,et al. Initiation of vasopressor infusions via peripheral versus central access in patients with early septic shock: A retrospective cohort study , 2020, Emergency medicine Australasia : EMA.
[47] Y. Mehta,et al. Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017. , 2020, JAMA.
[48] Shenmin Zhang,et al. Terlipressin for the treatment of septic shock in adults: a systematic review and meta-analysis , 2020, BMC Anesthesiology.
[49] С. В. Сидоренко,et al. МЕДОДИЧЕСКИЕ РЕКОМЕНДАЦИИ Российской некоммерческой общественной организации «Ассоциация анестезиологов-реаниматологов», Межрегиональной общественной организации «Альянс клинических химиотерапевтов и микробиологов», Межрегиональной ассоциации по клинической микробиологии и антимикробной химиотерапии , 2020 .
[50] A. A. Solodov,et al. Диагностика и интенсивная терапия острого респираторного дистресс-синдрома (Клинические рекомендации Общероссийской общественной организации «Федерация анестезиологов и реаниматологов») , 2020 .
[51] J. D. Young,et al. Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients With Vasodilatory Hypotension: A Randomized Clinical Trial. , 2020, JAMA.
[52] Sanmarié Schlebusch,et al. Antimicrobial-associated harm in critical care: a narrative review , 2020, Intensive Care Medicine.
[53] O. Uzundere,et al. Efficacy of HA330 Hemoperfusion Adsorbent in Patients Followed in the Intensive Care Unit for Septic Shock and Acute Kidney Injury and Treated with Continuous Venovenous Hemodiafiltration as Renal Replacement Therapy , 2020, Blood Purification.
[54] Е. В. Фот,et al. ЦЕЛЕНАПРАВЛЕННАЯ ДЕГИДРАТАЦИОННАЯ ТЕРАПИЯ ПРИ СЕПСИСЕ И ОСТРОМ РЕСПИРАТОРНОМ ДИСТРЕСС-СИНДРОМЕ ПОД КОНТРОЛЕМ ВОЛЮМЕТРИЧЕСКОГО МОНИТОРИНГА ГЕМОДИНАМИКИ , 2020 .
[55] R. Bellomo,et al. Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial. , 2020, JAMA.
[56] M. Rech,et al. Delayed vasopressor initiation is associated with increased mortality in patients with septic shock. , 2019, Journal of critical care.
[57] A. Delaney,et al. Safety of peripheral administration of vasopressor medications: A systematic review , 2019, Emergency medicine Australasia : EMA.
[58] W. Schaffner,et al. The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor - Active Surveillance in Selected Sites, United States, 2014-17. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[59] W. Alhazzani,et al. Predictors of gastrointestinal bleeding in adult ICU patients: a systematic review and meta-analysis , 2019, Intensive Care Medicine.
[60] M. Soliman,et al. Early Use of Norepinephrine Improves Survival in Septic Shock: Earlier than Early. , 2019, Archives of medical research.
[61] J. Vincent,et al. Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock: A randomized crossover double-blind study , 2019, PloS one.
[62] Ken Okamoto,et al. Liberal versus restrictive red blood cell transfusion strategy in sepsis or septic shock: a systematic review and meta-analysis of randomized trials , 2019, Critical Care.
[63] M. Nogueira,et al. Excess mortality is associated with influenza A (H1N1) in patients with severe acute respiratory illness. , 2019, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[64] K. Itani,et al. Association of Duration and Type of Surgical Prophylaxis With Antimicrobial-Associated Adverse Events. , 2019, JAMA surgery.
[65] T. Shin,et al. Impact of timing to source control in patients with septic shock: A prospective multi-center observational study. , 2019, Journal of critical care.
[66] J. Chiche,et al. Formal guidelines: management of acute respiratory distress syndrome , 2019, Annals of Intensive Care.
[67] S. Chevret,et al. Mottling score is a strong predictor of 14-day mortality in septic patients whatever vasopressor doses and other tissue perfusion parameters , 2019, Critical Care.
[68] Jeremy C. Weiss,et al. Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. , 2019, JAMA.
[69] Chao Qi,et al. Rapid Detection of Methicillin‐Resistant Staphylococcus aureus in BAL: A Pilot Randomized Controlled Trial , 2019, Chest.
[70] D. Eggink,et al. Viral Factors Associated With the High Mortality Related to Human Infections With Clade 2.1 Influenza A/H5N1 Virus in Indonesia , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[71] G. Martin,et al. Crystalloids vs. colloids for fluid resuscitation in the Intensive Care Unit: A systematic review and meta‐analysis , 2019, Journal of critical care.
[72] T. Rimmele,et al. oXiris® Use in Septic Shock: Experience of Two French Centres , 2019, Blood Purification.
[73] J. Bakker,et al. Narrative review: clinical assessment of peripheral tissue perfusion in septic shock , 2019, Annals of Intensive Care.
[74] Z. Molnár,et al. Extracorporeal cytokine adsorption in septic shock: A proof of concept randomized, controlled pilot study , 2019, Journal of critical care.
[75] M. Kollef,et al. Duration of Exposure to Antipseudomonal β‐Lactam Antibiotics in the Critically Ill and Development of New Resistance , 2019, Pharmacotherapy.
[76] D. Wolk,et al. Rapid Diagnostics for Blood Cultures: Supporting Decisions for Antimicrobial Therapy and Value-Based Care. , 2019, The journal of applied laboratory medicine.
[77] M. Kollef,et al. Outcomes Associated With De‐escalating Therapy for Methicillin‐Resistant Staphylococcus aureus in Culture‐Negative Nosocomial Pneumonia , 2019, Chest.
[78] S. Bagshaw,et al. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial , 2018, Intensive Care Medicine.
[79] M. A. Odena,et al. Proteolysis in septic shock patients: plasma peptidomic patterns are associated with mortality , 2018, British journal of anaesthesia.
[80] J. Marshall,et al. Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial , 2018, JAMA.
[81] M. Singer,et al. Antibiotics for Sepsis-Finding the Equilibrium. , 2018, JAMA.
[82] D. Wyncoll,et al. Refractory septic shock: our pragmatic approach , 2018, Critical Care.
[83] M. Nijsten,et al. Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials , 2018, Critical Care.
[84] M. Martín-Fernández,et al. Shared Features of Endothelial Dysfunction between Sepsis and Its Preceding Risk Factors (Aging and Chronic Disease) , 2018, Journal of clinical medicine.
[85] Manu L. N. G. Malbrain,et al. Principles of fluid management and stewardship in septic shock: it is time to consider the four D’s and the four phases of fluid therapy , 2018, Annals of Intensive Care.
[86] A. Delaney,et al. Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis , 2018, Intensive Care Medicine.
[87] M. Singer,et al. Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study) , 2018, Intensive Care Medicine.
[88] L. Epstein,et al. Risk of Subsequent Sepsis Within 90 Days After a Hospital Stay by Type of Antibiotic Exposure , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[89] T. Shin,et al. Prognosis of patients excluded by the definition of septic shock based on their lactate levels after initial fluid resuscitation: a prospective multi-center observational study , 2018, Critical Care.
[90] A. Dondorp,et al. Haemodynamic assessment and support in sepsis and septic shock in resource-limited settings , 2017, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[91] M. Amato,et al. Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial , 2017, JAMA.
[92] S. Hashemzadeh,et al. Albumin As a Resuscitative Fluid in Patients with Severe Sepsis: A Randomized Clinical Trial , 2017 .
[93] S. Cosgrove,et al. Association of Adverse Events With Antibiotic Use in Hospitalized Patients , 2017, JAMA internal medicine.
[94] N. Takeyama,et al. Early evaluation of severity in patients with severe sepsis: a comparison with “septic shock” — subgroup analysis of the Japanese Association for Acute Medicine Sepsis Registry (JAAM‐SR) , 2017, Acute medicine & surgery.
[95] T. van der Poll,et al. Short-Course Adjunctive Gentamicin as Empirical Therapy in Patients With Severe Sepsis and Septic Shock: A Prospective Observational Cohort Study , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[96] K. Soni,et al. Levosimendan does not provide mortality benefit over dobutamine in adult patients with septic shock: A meta-analysis of randomized controlled trials. , 2017, Journal of clinical anesthesia.
[97] G. Guyatt,et al. A systematic review of vasopressor blood pressure targets in critically ill adults with hypotension , 2017, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.
[98] M. Levy,et al. Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trial , 2017, Intensive Care Medicine.
[99] T. Lange,et al. Immunoglobulin G for patients with necrotising soft tissue infection (INSTINCT): a randomised, blinded, placebo-controlled trial , 2017, Intensive Care Medicine.
[100] Alan E. Jones,et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 , 2017, Intensive Care Medicine.
[101] G. Angelini,et al. The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta‐analysis of randomized trials , 2017, Journal of critical care.
[102] S. Karanika,et al. Colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae and risk for infection among patients with solid or haematological malignancy: a systematic review and meta-analysis. , 2016, International journal of antimicrobial agents.
[103] C. Brun-Buisson,et al. Septic shock with no diagnosis at 24 hours: a pragmatic multicenter prospective cohort study , 2016, Critical Care.
[104] Arthur S Slutsky,et al. Correction to: Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study , 2018, Intensive care medicine.
[105] B. Rochwerg,et al. How safe is gelatin? A systematic review and meta-analysis of gelatin-containing plasma expanders vs crystalloids and albumin. , 2016, Journal of critical care.
[106] J. Wernerman,et al. Long-term outcomes in patients with septic shock transfused at a lower versus a higher haemoglobin threshold: the TRISS randomised, multicentre clinical trial , 2016, Intensive Care Medicine.
[107] G. Perkins,et al. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial. , 2016, JAMA.
[108] Y. Mirzanejad,et al. The impact of delayed biliary decompression and anti‐microbial therapy in 260 patients with cholangitis‐associated septic shock , 2016, Alimentary pharmacology & therapeutics.
[109] Xiaoping Zhou,et al. Prognostic value of extravascular lung water and its potential role in guiding fluid therapy in septic shock after initial resuscitation. , 2016, Journal of critical care.
[110] J. Kellum,et al. Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial. , 2016, JAMA.
[111] M. Amato,et al. Understanding recruitment maneuvers , 2016, Intensive Care Medicine.
[112] S. Park,et al. Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment , 2016, PloS one.
[113] M. Balaan,et al. Acute Respiratory Distress Syndrome , 2016, Critical care nursing quarterly.
[114] R. Bosman,et al. The association between lactate, mean arterial pressure, central venous oxygen saturation and peripheral temperature and mortality in severe sepsis: a retrospective cohort analysis , 2016, Critical Care.
[115] Christopher W Seymour,et al. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.
[116] T. Rea,et al. Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.
[117] Sangeeta Mehta,et al. Higher versus lower blood pressure targets for vasopressor therapy in shock: a multicentre pilot randomized controlled trial , 2016, Intensive Care Medicine.
[118] J. Sobel,et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[119] Adil Rafiq Rather,et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) , 2015 .
[120] Can Ince,et al. Hemodynamic coherence and the rationale for monitoring the microcirculation , 2015, Critical Care.
[121] T. van der Poll,et al. Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study , 2015, Critical Care.
[122] S. Koenig,et al. Safety of peripheral intravenous administration of vasoactive medication. , 2015, Journal of hospital medicine.
[123] H. Trappe,et al. Earliest Bedside Assessment of Hemodynamic Parameters and Cardiac Biomarkers: Their Role as Predictors of Adverse Outcome in Patients with Septic Shock , 2015, International journal of medical sciences.
[124] Leonard Leibovici,et al. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis , 2015, PloS one.
[125] R. Green,et al. A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters. , 2015, Journal of critical care.
[126] J. D. De Waele,et al. Subtleties in practical application of prolonged infusion of β-lactam antibiotics. , 2015, International journal of antimicrobial agents.
[127] G. Guyatt,et al. Fluid type and the use of renal replacement therapy in sepsis: a systematic review and network meta-analysis , 2015, Intensive Care Medicine.
[128] G Greub,et al. Blood culture-based diagnosis of bacteraemia: state of the art. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[129] L. Harrison,et al. Declining Incidence of Candidemia and the Shifting Epidemiology of Candida Resistance in Two US Metropolitan Areas, 2008–2013: Results from Population-Based Surveillance , 2015, PloS one.
[130] F. Guo,et al. A high mean arterial pressure target is associated with improved microcirculation in septic shock patients with previous hypertension: a prospective open label study , 2015, Critical Care.
[131] Pierre Asfar,et al. Optimizing mean arterial pressure in septic shock: a critical reappraisal of the literature , 2015, Critical Care.
[132] J. Navarro-Martínez,et al. Comments on Cecconi et al.: Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine , 2015, Intensive Care Medicine.
[133] D. Cook,et al. The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis , 2014, Critical Care.
[134] C. Ince,et al. Dissociation between sublingual and gut microcirculation in the response to a fluid challenge in postoperative patients with abdominal sepsis , 2014, Annals of Intensive Care.
[135] B. Zhao,et al. Intensive Insulin Therapy for Septic Patients: A Meta-Analysis of Randomized Controlled Trials , 2014, BioMed research international.
[136] Anand Kumar,et al. Timing of vasopressor initiation and mortality in septic shock: a cohort study , 2014, Critical Care.
[137] P. Böelle,et al. Capillary refill time exploration during septic shock , 2014, Intensive Care Medicine.
[138] K. Kinoshita,et al. Time from admission to initiation of surgery for source control is a critical determinant of survival in patients with gastrointestinal perforation with associated septic shock , 2014, Critical Care.
[139] J. Marshall,et al. Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study , 2014, Critical Care.
[140] J. Rodríguez-Baño,et al. Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[141] L. Winston,et al. Risk factors for methicillin-resistant Staphylococcus aureus in patients with community-onset and hospital-onset pneumonia. , 2013, Respiratory medicine.
[142] M. Møller,et al. Surgical delay is a critical determinant of survival in perforated peptic ulcer , 2013, The British journal of surgery.
[143] Meng-Chih Lee,et al. Impact of timing of surgery on outcome of Vibrio vulnificus-related necrotizing fasciitis. , 2013, American journal of surgery.
[144] M. Kollef,et al. A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia , 2013, BMC Infectious Diseases.
[145] J. Rodríguez-Baño,et al. Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia. , 2013, The Journal of antimicrobial chemotherapy.
[146] J. Wetterslev,et al. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis , 2013, BMJ : British Medical Journal.
[147] H. Borthwick,et al. Does lactate measurement performed on admission predict clinical outcome on the intensive care unit? A concise systematic review , 2012, Annals of clinical biochemistry.
[148] Joshua A. Doherty,et al. Septic shock attributed to Candida infection: importance of empiric therapy and source control. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[149] V. Kuzkov,et al. Increased Extravascular Lung Water Reduces the Efficacy of Alveolar Recruitment Maneuver in Acute Respiratory Distress Syndrome , 2012, Critical care research and practice.
[150] J. Sobel,et al. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[151] J. Gonçalves-Pereira,et al. Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams , 2011, Critical care.
[152] P. Böelle,et al. Mottling score predicts survival in septic shock , 2011, Intensive Care Medicine.
[153] P. V. D. van der Voort,et al. Mean glucose during ICU admission is related to mortality by a U-shaped curve in surgical and medical patients: a retrospective cohort study , 2010, Critical care.
[154] Grace Y Chen,et al. Sterile inflammation: sensing and reacting to damage , 2010, Nature Reviews Immunology.
[155] L. Leibovici,et al. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. , 2010, The Journal of antimicrobial chemotherapy.
[156] J. Horton,et al. Etiology of illness in patients with severe sepsis admitted to the hospital from the emergency department. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[157] A. Nathens,et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. , 2010, Surgical infections.
[158] Johan Groeneveld,et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study , 2009, Intensive Care Medicine.
[159] D. Marriott,et al. Determinants of mortality in non-neutropenic ICU patients with candidaemia , 2009, Critical care.
[160] D. Warren,et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[161] C. Ince,et al. Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study , 2009, Critical care.
[162] E. Anaissie,et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[163] Deborah J. Cook,et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data , 2009, Canadian Medical Association Journal.
[164] Stephan M. Jakob,et al. Arterial blood pressure during early sepsis and outcome , 2009, Intensive Care Medicine.
[165] John A. Jones,et al. Incidence of systemic fungal infection and related mortality following severe burns. , 2008, Burns : journal of the International Society for Burn Injuries.
[166] Therapy Study Investigators,et al. A comparison of epinephrine and norepinephrine in critically ill patients , 2008, Intensive Care Medicine.
[167] J. Parrillo,et al. Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis , 2008, Intensive Care Medicine.
[168] D. Kontoyiannis,et al. The changing epidemiology of invasive candidiasis , 2008, Cancer.
[169] T. Calandra,et al. Bench-to-bedside review: Candida infections in the intensive care unit , 2008, Critical care.
[170] J. Paratz,et al. Continuous infusion of β-lactam antibiotics in severe infections: a review of its role , 2007 .
[171] K. Walley,et al. Myocardial hypoxia-inducible HIF-1alpha, VEGF, and GLUT1 gene expression is associated with microvascular and ICAM-1 heterogeneity during endotoxemia. , 2007, American journal of physiology. Heart and circulatory physiology.
[172] L. Cancio,et al. Fungal Wound Infection (Not Colonization) Is Independently Associated With Mortality in Burn Patients , 2007, Annals of surgery.
[173] P. Cabrales,et al. Microvascular and capillary perfusion following glycocalyx degradation. , 2007, Journal of applied physiology.
[174] J. Kellum,et al. Hyperchloremic acidosis increases circulating inflammatory molecules in experimental sepsis. , 2006, Chest.
[175] B. Levy. Lactate and shock state: the metabolic view , 2006, Current opinion in critical care.
[176] K. Garey,et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[177] V. Pettilä,et al. Hemodynamic variables related to outcome in septic shock , 2005, Intensive Care Medicine.
[178] J. Vincent,et al. Red blood cell rheology in sepsis , 2003, Intensive Care Medicine.
[179] M. Rybak,et al. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[180] A. Sandilands,et al. Greater inotropic and cyclic AMP responses evoked by noradrenaline through Arg389 β1‐adrenoceptors versus Gly389 β1‐adrenoceptors in isolated human atrial myocardium , 2003, British journal of pharmacology.
[181] R. Busund,et al. Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial , 2002, Intensive Care Medicine.
[182] K. Giercksky,et al. Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations. , 2002, Critical care medicine.
[183] J. Kellum. Fluid resuscitation and hyperchloremic acidosis in experimental sepsis: Improved short-term survival and acid-base balance with Hextend compared with saline , 2002, Critical care medicine.
[184] F B Taylor,et al. Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation , 2001, Thrombosis and Haemostasis.
[185] L. Saiman,et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[186] E. Rackow,et al. Effects of perfusion pressure on tissue perfusion in septic shock , 2000, Critical care medicine.
[187] W. Sibbald,et al. Endotoxin promotes adhesion of human erythrocytes to human vascular endothelial cells under conditions of flow , 2000, Critical care medicine.
[188] M M Hirschl,et al. Accuracy of oscillometric blood pressure measurement according to the relation between cuff size and upper‐arm circumference in critically ill patients , 2000, Critical care medicine.
[189] W. Sessa,et al. Vasomotor control in arterioles of the mouse cremaster muscle , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[190] David M. Shade,et al. Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. , 1999, Critical care medicine.
[191] M. Bedel,et al. The effect of intravenous lactated Ringer's solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. , 1999, Anesthesia and analgesia.
[192] F Lemaire,et al. Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trail Group on Tidal Volume reduction in ARDS. , 1998, American journal of respiratory and critical care medicine.
[193] D. Pittet,et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. , 1995, JAMA.
[194] M. Lamy,et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.
[195] M. V. Zakharov,et al. Dynamics of endotoxin activity and cytokine concentration in patients with septic shock and acute kidney injury undergoing various methods of extracorporeal detoxification , 2022, Anesteziologiya i reanimatologiya.
[196] OUP accepted manuscript , 2022, Clinical Kidney Journal.
[197] Chung-Chi Huang,et al. Outcomes of severe H1N1 pneumoniae: A retrospective study at intensive care units. , 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.
[198] J. Sciarretta,et al. Rapid Source-Control Laparotomy: Is There a Mortality Benefit in Septic Shock? , 2018, Surgical infections.
[199] T. van der Poll,et al. Biomarkers in Sepsis. , 2018, Critical care clinics.
[200] M. Kutuk,et al. A single-center experience with resin adsorption hemoperfusion combined with continuous veno-venous hemofiltration for septic shock patients , 2018 .
[201] Stein Silva,et al. Hemodynamic Assessment of Patients With Septic Shock Using Transpulmonary Thermodilution and Critical Care Echocardiography: A Comparative Study , 2018, Chest.
[202] J. Bakker,et al. Circulatory shock: An update A tribute to Professor Max Harry Weil , 2012 .
[203] Gabriele Neumann,et al. H5N1 influenza viruses: outbreaks and biological properties , 2010, Cell Research.
[204] Nancy Ballard,et al. Patients' recollections of therapeutic paralysis in the intensive care unit. , 2006, American journal of critical care : an official publication, American Association of Critical-Care Nurses.